Caris Life Sciences, Inc.
CAI
$27.24
$1.134.33%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 755.49M | 721.18M | 33.43M | -- | |
| Total Receivables | 26.70M | 50.89M | 80.17M | -- | |
| Inventory | 49.30M | 40.61M | 36.55M | -- | |
| Prepaid Expenses | 18.66M | 16.58M | 11.92M | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 4.10M | 4.06M | 9.16M | -- | |
| Total Current Assets | 854.25M | 833.32M | 171.23M | -- | |
|
|
|||||
| Total Current Assets | 854.25M | 833.32M | 171.23M | -- | |
| Net Property, Plant & Equipment | 64.00M | 61.32M | 61.65M | -- | |
| Long-term Investments | 19.34M | 19.34M | 19.34M | -- | |
| Goodwill | 19.34M | 19.34M | 19.34M | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 46.99M | 41.08M | 39.36M | -- | |
| Total Assets | 984.57M | 955.06M | 291.58M | -- | |
|
|
|||||
| Total Accounts Payable | 29.00M | 28.73M | 24.23M | -- | |
| Total Accrued Expenses | 47.63M | 48.73M | 64.55M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 6.61M | 7.39M | 66.12M | -- | |
| Total Finance Division Other Current Liabilities | 2.79M | 5.34M | 7.66M | -- | |
| Total Other Current Liabilities | 2.79M | 5.34M | 7.66M | -- | |
| Total Current Liabilities | 86.03M | 90.18M | 162.55M | -- | |
|
|
|||||
| Total Current Liabilities | 86.03M | 90.18M | 162.55M | -- | |
| Long-Term Debt | 376.30M | 373.61M | 316.64M | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | 43.83M | 37.98M | 37.07M | -- | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | 53.00K | 380.00K | 129.07M | -- | |
| Total Liabilities | 506.21M | 502.15M | 645.34M | -- | |
|
|
|||||
| Common Stock & APIC | 3.13B | 3.12B | 145.00K | -- | |
| Retained Earnings | -2.63B | -2.66B | -2.58B | -- | |
| Treasury Stock & Other | -16.17M | -16.25M | -16.67M | -- | |
| Total Common Equity | 478.36M | 452.90M | -2.60B | -- | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | 2.25B | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | 2.25B | -- | |
|
|
|||||
| Total Common Equity | 478.36M | 452.90M | -2.60B | -- | |
| Total Preferred Equity | -- | -- | 2.25B | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 478.36M | 452.90M | -353.75M | -- | |
|
|
|||||